EFG Asset Management (Americas)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,692
Closed -$235K 127
2024
Q1
$235K Sell
1,692
-1,009
-37% -$127K 0.07% 121
2023
Q4
$335K Sell
2,701
-682
-20% -$69.7K 0.07% 122
2023
Q3
$316K Sell
3,383
-100
-3% -$11.3K 0.08% 124
2023
Q2
$448K Sell
3,483
-396
-10% -$47.9K 0.1% 111
2023
Q1
$451K Sell
3,879
-289
-7% -$32.4K 0.11% 107
2022
Q4
$472K Sell
4,168
-444
-10% -$48.7K 0.12% 103
2022
Q3
$371K Hold
4,612
0.09% 110
2022
Q2
$344K Sell
4,612
-24
-0.5% -$2.19K 0.08% 113
2022
Q1
$593K Buy
4,636
+404
+10% +$44.2K 0.11% 106
2021
Q4
$568K Buy
4,232
+60
+1% +$8.62K 0.1% 112
2021
Q3
$570K Sell
4,172
-132
-3% -$16.6K 0.1% 112
2021
Q2
$459K Buy
4,304
+888
+26% +$85.3K 0.09% 115
2021
Q1
$307K Buy
3,416
+928
+37% +$87.1K 0.06% 126
2020
Q4
$230K Buy
2,488
+212
+9% +$18.9K 0.05% 134
2020
Q3
$235K Buy
+2,276
New +$238K 0.05% 126
2017
Q4
Sell
-23,136
Closed -$283K 131
2017
Q3
$283K Buy
23,136
+5,876
+34% +$104K 0.11% 124
2017
Q2
$316K Buy
17,260
+7,224
+72% +$133K 0.12% 111
2017
Q1
$213K Buy
+10,036
New +$196K 0.08% 113

Other funds holding DXCM